Gras-Champel V - Search Results

1

Adverse Drug Reactions in Patients with CKD.

Laville SM, Gras-Champel V, Moragny J, Metzger M, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Robinson BM, Stengel B, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. Laville SM, et al. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1090-1102. doi: 10.2215/CJN.01030120. Epub 2020 Jul 1. Clin J Am Soc Nephrol. 2020. PMID: 32611662 Free PMC article.

2

[Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers].

Roskiewicz F, Andriamanana I, Gras-Champel V, Andrejak M, Massy ZA. Roskiewicz F, et al. Nephrol Ther. 2007 Jun;3(3):89-95. doi: 10.1016/j.nephro.2007.03.003. Epub 2007 Apr 18. Nephrol Ther. 2007. PMID: 17540310 Review. French.

3

Lemaire-Hurtel AS, Gras-Champel V, Hary L, Masmoudi K, Massy Z, Andréjak M. Lemaire-Hurtel AS, et al. Nephrol Ther. 2009 Apr;5(2):144-8. doi: 10.1016/j.nephro.2008.10.004. Epub 2008 Dec 13. Nephrol Ther. 2009. PMID: 19071080 French.

4

[Quantification of the part allocated to the preventability of vitamin K antagonists therapy bleeding events].

Gras-Champel V, Brenet-Dufour V, Moragny J, Masson H, Davidau E, Masmoudi K, Andrejak M. Gras-Champel V, et al. Therapie. 2010 May-Jun;65(3):261-8. doi: 10.2515/therapie/2010010. Epub 2010 Aug 11. Therapie. 2010. PMID: 20699080 French.

5

Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.

Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, Haramburu F; EMIR Study Group on behalf of the French network of pharmacovigilance centres. Bénard-Laribière A, et al. Fundam Clin Pharmacol. 2015 Feb;29(1):106-11. doi: 10.1111/fcp.12088. Epub 2014 Sep 25. Fundam Clin Pharmacol. 2015. PMID: 24990220

6

Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists.

Liabeuf S, Scaltieux LM, Masmoudi K, Roussel B, Moragny J, Andrejak M, Gras-Champel V. Liabeuf S, et al. Medicine (Baltimore). 2015 Dec;94(52):e2366. doi: 10.1097/MD.0000000000002366. Medicine (Baltimore). 2015. PMID: 26717378 Free PMC article.

7

Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists.

Liabeuf S, Masmoudi K, Scailteux LM, Moragny J, Masson H, Brnet-Dufour V, Andrejak M, Gras-Champel V. Liabeuf S, et al. Medicine (Baltimore). 2016 Sep;95(39):e4762. doi: 10.1097/MD.0000000000004762. Medicine (Baltimore). 2016. PMID: 27684801 Free PMC article.

8

Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.

Gras-Champel V, Batteux B, Masmoudi K, Liabeuf S. Gras-Champel V, et al. Muscle Nerve. 2019 Oct;60(4):382-386. doi: 10.1002/mus.26637. Epub 2019 Jul 29. Muscle Nerve. 2019. PMID: 31298743

9

Statin-associated myasthenia: A case report and literature review.

Gras-Champel V, Masmoudi I, Batteux B, Merle PE, Liabeuf S, Masmoudi K. Gras-Champel V, et al. Therapie. 2020 May-Jun;75(3):301-309. doi: 10.1016/j.therap.2019.07.004. Epub 2019 Jul 26. Therapie. 2020. PMID: 31477339 Review. No abstract available.

10

Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study.

Rey A, Batteux B, Laville SM, Marienne J, Masmoudi K, Gras-Champel V, Liabeuf S. Rey A, et al. Arthritis Res Ther. 2019 Nov 8;21(1):229. doi: 10.1186/s13075-019-2011-y. Arthritis Res Ther. 2019. PMID: 31703711 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters